GHRSGH Research PLC

$1B

Q1 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$12M

Net Income

-$8M

EPS (Diluted)

$-0.15

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$10M

Stock-Based Comp.

$300,000

Balance Sheet

Total Assets

$218M

Total Liabilities

$8M

Stockholders' Equity

$210M

Cash & Equivalents

$77M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$12M	-$10M	-10.6%
Net Income	-$8M	-$11M	+29.9%

GHRS Q1 2024 Earnings — GH Research PLC Revenue & Financial Results | Market Cap Arena